The Evaluation and Comparison of BCR-ABL p210 mRNA Transcripts (%IS Unit) Results Between Dr. PCR ™ BCR-ABL1 Major IS Detection Kit (Optolane) and QXDx™ BCR-ABL %IS Kit (Bio-Rad) in Chronic Myeloid Leukemia Patients
Conditions: Chronic Myelogenous Leukemia Sponsors: Siriraj Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2024 Category: Research Source Type: clinical trials
UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trial
DiscussionBased on preclinical and early pilot clinical evidence, we want to test the novel concept of temporary (lymph)angioregressive pretreatment of high-risk eyes by CXL to promote subsequent corneal graft survival. So far, there is no evidence-based approach to reliably improve graft survival in the high-risk corneal transplantation setting available in clinical routine. If successful, this approach will be the first to promote graft survival in high-risk transplants. It will significantly improve vision and quality of life in patients suffering from corneal blindness.Trial registrationClinicalTrials.gov NCT05870566. ...
Source: Trials - March 6, 2024 Category: Research Source Type: clinical trials
Comparison Between Peribulbar And Sub-tenon Blocks on Oculocardiac Reflex (OCR) During Pediatric Strabismus Surgery
Conditions: Anesthesia, Local; Ophthalmopathy; Strabismus; Pediatric ALL Interventions: Procedure: peribulbar block; Procedure: sub-tenon block; Drug: Paracetamol Sponsors: Cairo University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
Ocular Trauma and COVID-19 in Indonesia
Conditions: Ophthalmological Disorder; Ocular Injury; COVID-19 Sponsors: Prof. R. D. Kandou General Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Impact of Surgical Approach on Adaptation of Posture-respiratory Coupling
Conditions: Resectable Lung Non-Small Cell Carcinoma Interventions: Other: EOS imaging for musculoskeletal disorder; Other: Movement analysis by an optoelectronic camera.; Other: Stabilometric measurement by strength platform Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
Conditions: Thyroid Eye Disease; Graves Ophthalmopathy; Graves Disease Interventions: Drug: Teprotumumab Injection [Tepezza] Sponsors: Walter Reed National Military Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II
Conditions: Bacterial Keratitis Interventions: Drug: Difluprednate Ophthalmic; Drug: Rose Bengal; Drug: Moxifloxacin Ophthalmic Sponsors: University of California, San Francisco; Stanford University; Aravind Eye Care System; Federal University of S ão Paulo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
Exploring the Interaction Between Metabolic Disorders and NLPR3 Inflammasome Activation in DR Inflammatory Damage
Conditions: Diabetic Retinopathy; Diabetic Macular Edema; Anti-vascular Endothelial Growth Factor Sponsors: Zhongshan Ophthalmic Center, Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials
P200TxE Diseased Eye Image Collection
Conditions: Retinal Disease Interventions: Device: P200TxE Sponsors: Optos, PLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Chinese Healthy Adult Subjects With Presbyopia
Conditions: Presbyopia Interventions: Drug: LNZ101 (Aceclidine /Brimonidine) ophthalmic solution; Drug: LNZ100 (Aceclidine) ophthalmic solution; Drug: Placebo (Vehicle) ophthalmic solution Sponsors: Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.; LENZ Therapeutics, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
A Study of IBI311 in Subjects With Steroid-resistant, Thyroid Associated Ophthalmopathy
Conditions: Thyroid Associated Ophthalmopathy Interventions: Drug: Placebo; Drug: IBI311 Sponsors: Peking University People ' s Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
Safety, Tolerability and Pharmacokinetics of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Chinese With Presbyopia
Conditions: Presbyopia Interventions: Drug: LNZ101 (Aceclidine /Brimonidine) ophthalmic solution; Drug: LNZ100 (Aceclidine) ophthalmic solution; Drug: Placebo (Vehicle) ophthalmic solution Sponsors: Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.; LENZ Therapeutics, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2024 Category: Research Source Type: clinical trials
Effects of Autostereoscopic 3D Visual Training on Binocular Vision Function of Myopes
Conditions: Myopia Interventions: Other: Visual training video Sponsors: Zhongshan Ophthalmic Center, Sun Yat-sen University; South China University of Technology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
Conditions: Open-angle Glaucoma; Ocular Hypertension Interventions: Drug: Bimatoprost Ophthalmic Solution, 0.01%; Drug: LUMIGAN ® (bimatoprost ophthalmic solution) 0.01% Sponsors: Amneal Pharmaceuticals, LLC; CBCC Global Inc.; Amneal EU, Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
T30 for Astigmatism in Digital Device Users
Conditions: Contact Lens Complication; Astigmatism; Refractive Errors Interventions: Device: Total30 for Astigmatism Contact Lenses Sponsors: Southern College of Optometry; Alcon Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
